Publications in collaboration with researchers from Universitat de València (66)

2025

  1. Methylomic signature of current cannabis use in two first-episode psychosis cohorts

    Molecular Psychiatry, Vol. 30, Núm. 4, pp. 1277-1286

  2. Variation of subclinical psychosis as a function of population density across different European settings: Findings from the multi-national EU-GEI study

    Acta Psychiatrica Scandinavica, Vol. 151, Núm. 4, pp. 506-520

2024

  1. Accelerated Cortical Thinning in Schizophrenia Is Associated With Rare and Common Predisposing Variation to Schizophrenia and Neurodevelopmental Disorders

    Biological Psychiatry, Vol. 96, Núm. 5, pp. 376-389

  2. Clustering Schizophrenia Genes by Their Temporal Expression Patterns Aids Functional Interpretation

    Schizophrenia Bulletin, Vol. 50, Núm. 2, pp. 327-338

  3. Processing speed mediates the relationship between DDR1 and psychosocial functioning in euthymic patients with bipolar disorder presenting psychotic symptoms

    Molecular Psychiatry, Vol. 29, Núm. 7, pp. 2050-2058

  4. Shared vulnerability and sex-dependent polygenic burden in psychotic disorders

    European Neuropsychopharmacology, Vol. 86, pp. 49-54

  5. Spanish validation of the Empirically Developed Clinical Staging Model (EmDe-5) for patients with bipolar disorder

    Spanish Journal of Psychiatry and Mental Health, Vol. 17, Núm. 4, pp. 215-221

  6. The Role of Social Deprivation and Cannabis Use in Explaining Variation in the Incidence of Psychotic Disorders: Findings From the EU-GEI Study

    Schizophrenia Bulletin, Vol. 50, Núm. 5, pp. 1039-1049

  7. The effect of polygenic risk score and childhood adversity on transdiagnostic symptom dimensions at first-episode psychosis: evidence for an affective pathway to psychosis

    Translational Psychiatry, Vol. 14, Núm. 1

  8. The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies

    Psychological Medicine

  9. Variation of subclinical psychosis across 16 sites in Europe and Brazil: findings from the multi-national EU-GEI study

    Psychological medicine, Vol. 54, Núm. 8, pp. 1810-1823

2023

  1. Cannabis use as a potential mediator between childhood adversity and first-episode psychosis: Results from the EU-GEI case-control study

    Psychological Medicine, Vol. 53, Núm. 15, pp. 7375-7384

  2. Child maltreatment, migration and risk of first-episode psychosis: results from the multinational EU-GEI study

    Psychological Medicine, Vol. 53, Núm. 13, pp. 6150-6160

  3. Common genetic variants contribute to heritability of age at onset of schizophrenia

    Translational Psychiatry, Vol. 13, Núm. 1

  4. Correction: Common genetic variants contribute to heritability of age at onset of schizophrenia (Translational Psychiatry, (2023), 13, 1, (201), 10.1038/s41398-023-02508-0)

    Translational Psychiatry

  5. Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI Study

    Schizophrenia Bulletin, Vol. 49, Núm. 5, pp. 1269-1280

  6. Exploring the mediation of DNA methylation across the epigenome between childhood adversity and First Episode of Psychosis—findings from the EU-GEI study

    Molecular Psychiatry, Vol. 28, Núm. 5, pp. 2095-2106

  7. Recent natural selection conferred protection against schizophrenia by non-antagonistic pleiotropy

    Scientific Reports, Vol. 13, Núm. 1

  8. Synergistic effects of childhood adversity and polygenic risk in first-episode psychosis: The EU-GEI study

    Psychological Medicine, Vol. 53, Núm. 5, pp. 1970-1978

  9. The association between reasons for first using cannabis, later pattern of use, and risk of first-episode psychosis: the EU-GEI case-control study

    Psychological medicine, Vol. 53, Núm. 15, pp. 7418-7427